| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/30/2013 | US8497248 Antifungal paints and coatings |
| 07/30/2013 | US8497247 Methods for treating type I diabetes mellitus by administering a soluble CTLA4 molecule |
| 07/30/2013 | US8497245 Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors IIa and Xa |
| 07/30/2013 | US8497244 Methods for targeting pulmonary diseases with agents that bind a target in pulmonary tissue |
| 07/30/2013 | US8497243 Methods and compositions useful in the treatment of mucositis |
| 07/30/2013 | US8497242 Processes for intermediates for macrocyclic compounds |
| 07/30/2013 | US8497241 WNT10-derived peptide and use thereof |
| 07/30/2013 | US8497240 DPP-IV resistant GIP hybrid polypeptides with selectable properties |
| 07/30/2013 | US8497238 Composition for improving membrane composition and functioning cells |
| 07/30/2013 | US8497237 Compositions comprising enzyme-cleavable oxycodone prodrug |
| 07/30/2013 | US8497236 Implantable putty material |
| 07/30/2013 | US8497231 Evolved orthogonal ribosomes |
| 07/30/2013 | US8497101 Use of a new gene coding for a new member of the MCM2-8 family in pharmaceutical compositions |
| 07/30/2013 | US8496954 Coating systems for the controlled delivery of hydrophilic bioactive agents |
| 07/30/2013 | US8496945 Nanoparticle delivery systems for membrane-integrating peptides |
| 07/30/2013 | US8496943 Non-aqueous single phase vehicles and formulations utilizing such vehicles |
| 07/30/2013 | US8496942 Therapeutic peptides and uses thereof |
| 07/30/2013 | US8496933 VHNAR anti-cytokine domains |
| 07/30/2013 | US8496921 Consensus interferon variant and methods of suppressing viral activity |
| 07/30/2013 | CA2704083C Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene |
| 07/30/2013 | CA2701023C Methods and formulations for converting intravenous and injectable drugs into oral dosage forms |
| 07/30/2013 | CA2589889C Therapeutic formulations of keratinocyte growth factor |
| 07/30/2013 | CA2579720C A pharmaceutical composition for treating ataxia, multiple system atrophy or balance disorders |
| 07/30/2013 | CA2568201C Identification of ergothioneine transporter and therapeutic uses thereof |
| 07/30/2013 | CA2563400C Medicament for the treatment of fungal infections, particularly aspergillosis |
| 07/30/2013 | CA2551510C Stable growth hormone liquid formulation |
| 07/30/2013 | CA2523517C Bcl2l12 polypeptide activators and inhibitors |
| 07/30/2013 | CA2518944C Inhibitors of extracellular hsp90 |
| 07/30/2013 | CA2515335C Growth factor complexes and modulation of cell migration and growth |
| 07/30/2013 | CA2513213C Albumin fusion proteins |
| 07/30/2013 | CA2509241C Use of serum amyloid p (sap) and related compositions for the suppression of fibrosis-related diseases |
| 07/30/2013 | CA2480079C Antiangiogenic active immunotherapy |
| 07/30/2013 | CA2479764C Hemiasterlin derivatives and uses thereof |
| 07/30/2013 | CA2451874C Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells |
| 07/30/2013 | CA2425174C Human gene critical to fertility |
| 07/30/2013 | CA2422774C Remedies for amyotrophic lateral sclerosis |
| 07/30/2013 | CA2413754C Canine hepatocyte growth factor |
| 07/30/2013 | CA2276542C Novel peptide, a method for its preparation and a pharmaceutical composition containing the peptide |
| 07/25/2013 | WO2013110080A1 Cylindrins as etiologic agents of amyloid diseases |
| 07/25/2013 | WO2013110077A1 Topical therapeutic formulations |
| 07/25/2013 | WO2013110069A1 Glutamic acid-stabilized insulin analogues |
| 07/25/2013 | WO2013110050A1 Inulin and inulin acetate formulations |
| 07/25/2013 | WO2013109904A1 Compositions, methods and kits for treatment of cancer and autoimmune diseases |
| 07/25/2013 | WO2013109876A1 Enhanced glycemic control using ad36e4orf1 and akt1 inhibitor |
| 07/25/2013 | WO2013109811A1 Human placental derived extracellular matrix and uses thereof |
| 07/25/2013 | WO2013109752A1 High affinity sirp-alpha reagents |
| 07/25/2013 | WO2013109610A1 Pharmaceutical compositions and methods |
| 07/25/2013 | WO2013109488A1 Compositions and methods for treating diabetes and/or obesity |
| 07/25/2013 | WO2013109421A1 Liposomally encapsulated reduced glutathione for management of cancer and disruption of cancer energy cycles |
| 07/25/2013 | WO2013109342A1 Method of treating diabetes using non-glycosylated apolipoprotein a-iv |
| 07/25/2013 | WO2013108869A1 Therapeutic or prophylactic agent for cancer |
| 07/25/2013 | WO2013108780A1 AMYLOID β-PROTEIN-SPECIFIC PRODUCTION-INHIBITING POLYPEPTIDE |
| 07/25/2013 | WO2013108771A1 Method for extracting lysyl oxidase from eggshell membrane |
| 07/25/2013 | WO2013108235A1 Stabilized pth formulation |
| 07/25/2013 | WO2013108193A1 Synthetic peptides for treatment of bacterial infections |
| 07/25/2013 | WO2013107910A1 Neurological therapies |
| 07/25/2013 | WO2013107413A1 Use of phosphorylation pathway-related factor in regulating function of regulatory t cell |
| 07/25/2013 | WO2013107388A1 Interferon and immune globulin fc section fusion protein |
| 07/25/2013 | WO2013106909A1 Novel peptides and methods and uses thereof for preventing retinal disorders |
| 07/25/2013 | WO2013078199A3 Methods for enhanced in vivo delivery of synthetic, modified rnas |
| 07/25/2013 | WO2013076259A3 Polypeptides having lysozyme activity and polynucleotides encoding same |
| 07/25/2013 | WO2013072901A3 Compositions and methods for treating glioma |
| 07/25/2013 | WO2013024362A3 Cardiovascular therapeutics |
| 07/25/2013 | WO2011163423A3 Methods and compositions for cell permeable stat3 inhibitor |
| 07/25/2013 | US20130190407 Calcium receptor-active molecules |
| 07/25/2013 | US20130190391 Traversal of nucleic acid molecules through a fluid space and expression in repair cells |
| 07/25/2013 | US20130190300 Compositions and methods for inhibiting the proliferation of cells |
| 07/25/2013 | US20130190251 Method for predicting the responsiveness to chemotherapy |
| 07/25/2013 | US20130190250 Polynucleotides Encoding Human Signal Peptide-Containing Proteins |
| 07/25/2013 | US20130190249 Therapeutically active compositions and their methods of use |
| 07/25/2013 | US20130190247 Peptide antagonists of zonulin and methods for use of the same |
| 07/25/2013 | US20130190244 Methods for performing a coronary artery bypass graft procedure |
| 07/25/2013 | US20130190243 Pharmacological treatment of aortic aneurysm development |
| 07/25/2013 | US20130190239 Formulations Comprising Linaclotide |
| 07/25/2013 | US20130190238 Treatments for Gastrointestinal Disorders |
| 07/25/2013 | US20130190235 Fusion protein for antagonizing angiogenesis inducible factors and uses thereof |
| 07/25/2013 | US20130190233 Peptides, derivatives and analogs thereof, and methods of using same |
| 07/25/2013 | US20130190230 Compositions and methods for treating cognitive deficits |
| 07/25/2013 | US20130190229 Vitamin e formulations of sulfamide ns3 inhibitors |
| 07/25/2013 | US20130190226 Reconstituted high density lipoprotein formulation and production method thereof |
| 07/25/2013 | US20130190225 Use of Leptin for Treating Human Lipoatrophy and Method of Determining Predisposition to Said Treatment |
| 07/25/2013 | US20130190224 Treatment of fibrosis-related disorders using fibronectin binding proteins and polypeptides |
| 07/25/2013 | US20130190221 Monomeric recombinant mhc molecules useful for manipulation of antigen-specific t-cells |
| 07/25/2013 | US20130189678 Macrophage migration inhibitory factor (mif) promoter polymorphism in inflammatory disease |
| 07/25/2013 | US20130189346 Wound dressing |
| 07/25/2013 | US20130189344 Human lubrication gel |
| 07/25/2013 | US20130189338 Bone fibers having extended length |
| 07/25/2013 | US20130189330 Enteral Nutrient |
| 07/25/2013 | US20130189294 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 07/25/2013 | US20130189290 Vaccine for the prevention of breast cancer relapse |
| 07/25/2013 | US20130189276 Method inhibiting cell proliferation induced by alternatively spliced tissue factor |
| 07/25/2013 | US20130189275 Compositions and methods for inhibition of or treatment of dengue virus infection |
| 07/25/2013 | US20130189273 Eg-vegf nucleic acids and polypeptides and methods of use |
| 07/25/2013 | US20130189262 IL-27 Antagonists for Treating Inflammatory Diseases |
| 07/25/2013 | US20130189253 Modulation of sirp-alpha - cd47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
| 07/25/2013 | US20130189242 Hyaluronidase and Method of use Thereof |
| 07/25/2013 | US20130189240 Composition containing pias3 as an active ingredient for preventing or treating cancer or immune disease |
| 07/25/2013 | US20130189225 Methods of increasing efficiency of vector penetration of target tissue |
| 07/25/2013 | US20130189223 Methods and Compositions for Promoting Renal Repair and Regeneration |
| 07/25/2013 | US20130189219 N-terminally chemically modified protein compositions and methods |